| Active substance | Ostarine  | 
		
|---|---|
| Water Retention | Minimal  | 
		
| Hepatotoxicity | Mild risk  | 
		
| Lab Test | Detection in blood and urine through specific chromatographic techniques  | 
		
| Also known as | Enobosarm, GTx-024  | 
		
| Blood pressure | No significant impact  | 
		
| Trade name | Enobosarm  | 
		
| FORM | 50 tabs x 10 mg/tab  | 
		
| Storage conditions | Store at room temperature, away from moisture and light  | 
		
| Chemical name | (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide  | 
		
| Formula | C19H14F3N3O3  | 
		
| Substance class | Selective Androgen Receptor Modulator (SARM)  | 
		
| Main action | Anabolic, muscle growth stimulation  | 
		
| Half-life | 24 hours  | 
		
| Dosage (medical) | Not medically approved, no standard dosage  | 
		
| Dosage (sports) | 10-30 mg per day  | 
		
| Effects | Increases muscle mass and strength, improves bone density  | 
		
| Side effects | Possible liver toxicity, changes in lipid profiles, suppression of natural testosterone production  | 
		
| Use in sports | Used for muscle growth and performance enhancement, banned in professional sports  | 
		
| Manufacturer | Driada Medical  | 
		





There are no reviews yet.